immunotherapy plus tkis for the treatment of crc
Published 2 years ago • 58 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
0:46
key limitations of current treatment options for patients with mss-crc
-
2:18
dr. marshall discusses immunotherapy progress in the treatment of crc
-
0:47
the emerging role of immunotherapy for microsatellite stable colorectal cancer
-
1:23
the rationale for combining regorafenib with io to treat patients with refractory mss-crc
-
0:49
novel immunotherapy approaches for mmr-proficient colorectal cancer
-
6:56
prior rt may potentially enhance treatment of mss-crc with regorafenib and pembrolizumab
-
2:07
unanswered questions on the use of immunotherapy in crc
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
2:59
chemotherapy in combination with immunotherapy for the treatment of metastatic thymic carcinoma
-
0:55
enhancing the efficacy of immune checkpoint inhibitors in crc
-
35:42
immunotherapy in crc | 2023 best of gi cancer conference
-
0:41
how can immunotherapies successfully target mss colorectal cancer?
-
1:03
the role of crc predicative biomarkers in guiding treatment decisions
-
6:11
immunotherapy in crc
-
0:51
advances in immunotherapy for rectal cancer
-
1:55
the latest in targeted therapies for advanced colorectal cancer
-
4:16
understanding immunotherapy and colorectal cancer (crc)
-
2:40
regorafenib plus pembrolizumab for first-line treatment of advanced hcc